{"id":64854,"date":"2024-11-02T12:22:58","date_gmt":"2024-11-02T12:22:58","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=64854"},"modified":"2026-04-30T10:15:58","modified_gmt":"2026-04-30T10:15:58","slug":"raloxiheal","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/raloxiheal\/","title":{"rendered":"Raloxiheal"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:18px 0;border-radius:4px;\">\n<p style=\"margin:0 0 8px 0;\"><strong>\ud83d\udca1 R\u0103spuns rapid<\/strong><\/p>\n<p style=\"margin:0;\"><strong>Raloxiheal<\/strong> este <strong>raloxifene 60 mg<\/strong>, un modulator selectiv al receptorului de estrogen (SERM) cu aprobare dubl\u0103: <strong>prevenirea \u0219i tratamentul osteoporozei postmenopauzale<\/strong>, \u0219i <strong>reducerea riscului de cancer invaziv de s\u00e2n<\/strong> la femeile postmenopauzale cu risc ridicat. Spre deosebire de estrogen, raloxifena NU este un tratament hormonal de substitu\u021bie (THS) pentru senza\u021bia de c\u0103ldur\u0103 \u2014 poate \u00eenr\u0103ut\u0103\u021bi aceste simptome. Are un profil mai sigur \u00een ceea ce prive\u0219te cancerul de s\u00e2n dec\u00e2t estrogenul, dar un risc comparabil de tromboz\u0103 venoas\u0103 (VTE).<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Ce beneficii ofer\u0103 MedsBase:<\/strong> Produc\u0103tor certificat WHO-GMP \u00b7 Ambalaj discret \u00b7 Livrare la nivel mondial \u00b7 Peste 1.400 de recenzii verificate <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">ale clien\u021bilor<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n<div style=\"background:#f4f8fb;border-left:4px solid #2c7cb0;padding:14px 20px;margin:16px 0;border-radius:4px;font-size:0.95em;\">\n<strong>\ud83d\udd12 Ce beneficia\u021bi cu MedsBase:<\/strong> Produc\u0103tor certificat WHO-GMP \u00b7 Ambalaj discret simplu (f\u0103r\u0103 denumirea medicamentului pe exterior) \u00b7 Livrare worldwide \u00b7 Citeste-ne <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">Peste 1.400 de recenzii ale clien\u021bilor<\/a>\n<\/div>\n<h3>De ce s\u0103 comanzi de la MedsBase<\/h3>\n<p>Fiecare comand\u0103 MedsBase este expediat\u0103 de la un produc\u0103tor certificat WHO-GMP \u00een ambalaj simplu, complet discret \u2014 nimic pe exterior nu identific\u0103 con\u021binutul sau farmacia. Pl\u0103\u021bile cu cardul sunt procesate printr-un on-ramp crypto reglementat; descriptorul din extrasul de cont este numele procesatorului (un procesator de pl\u0103\u021bi cu card reglementat) \u2014 niciodat\u0103 \u201cMedsBase\u201d sau orice legat de farmacie. Pl\u0103\u021bile crypto prin Plisio r\u0103m\u00e2n complet anonime. Fiecare colet este acoperit de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\">Politica noastr\u0103 de Reexpediere Garantat\u0103<\/a>.<\/p>\n<h2><strong>Ce este Raloxiheal?<\/strong><\/h2>\n<p>Raloxiheal este un medicament generic marca a <strong>raloxifene 60 mg<\/strong>, un <strong>modulator selectiv al receptorului de estrogen (SERM)<\/strong>. SERM-urile au efecte asem\u0103n\u0103toare estrogenului \u00een unele \u021besuturi \u0219i efecte anti-estrogenice \u00een altele. Raloxifena imit\u0103 estrogenul \u00een os (efect pozitiv \u2014 cre\u0219te densitatea osoas\u0103), dar blocheaz\u0103 estrogenul \u00een \u021besutul mamar (efect pozitiv \u2014 reduce riscul de cancer de s\u00e2n). Are efecte neutre sau u\u0219oare asupra uterului (spre deosebire de tamoxifen, care poate cre\u0219te riscul de cancer endometrial). Produs de Healing Pharma.<\/p>\n<h2><strong>Indica\u021bii aprobate de FDA<\/strong><\/h2>\n<ul>\n<li><strong>Prevenirea osteoporozei postmenopauzale<\/strong> \u2014 de obicei la femei cu peste 5 ani de la menopauz\u0103 \u0219i cu pierdere moderat\u0103 a densit\u0103\u021bii osoase.<\/li>\n<li><strong>Tratamentul osteoporozei postmenopauzale<\/strong> \u2014 reduce riscul de fractur\u0103 vertebral\u0103 cu ~40\u201350% pe parcursul a 3 ani.<\/li>\n<li><strong>Reducerea riscului de cancer invaziv de s\u00e2n<\/strong> la femeile postmenopauzale cu risc ridicat. Studiul STAR a ar\u0103tat c\u0103 raloxifena 60 mg a redus riscul de cancer invaziv de s\u00e2n cu ~50% (similar cu tamoxifenul) cu mai pu\u021bine evenimente tromboembolice \u0219i un risc mai mic de cancer endometrial.<\/li>\n<\/ul>\n<h2><strong>C\u00e2nd Raloxifena Este Potrivit\u0103 Pentru Tine<\/strong><\/h2>\n<ul>\n<li><strong>Ave\u021bi<\/strong>: osteoporoz\u0103 SAU risc ridicat de cancer de s\u00e2n, v\u00e2rst\u0103 \u226560 sau cel pu\u021bin 5 ani de la menopauz\u0103<\/li>\n<li><strong>Nu ave\u021bi<\/strong>: soflete active (raloxifena le agraveaz\u0103), antecedente de tromboembolism venos, boli hepatice active, poten\u021bial de sarcin\u0103<\/li>\n<li><strong>Alternative:<\/strong> bifosfona\u021bi (alendronat, risedronat), denosumab, teriparatid\u0103 pentru osteoporoz\u0103; tamoxifen ca SERM alternativ pentru prevenirea cancerului de s\u00e2n (op\u021biune pentru premenopauz\u0103)<\/li>\n<\/ul>\n<h2><strong>Cum se administreaz\u0103<\/strong><\/h2>\n<ol>\n<li>Lua\u021bi <strong>o tablet\u0103 de 60 mg o dat\u0103 pe zi<\/strong>, \u00een orice moment, cu sau f\u0103r\u0103 m\u00e2ncare.<\/li>\n<li>Administra\u021bi cu un aport adecvat de calciu (1000\u20131200 mg\/zi) \u0219i vitamina D (800\u20131000 UI\/zi) \u2014 raloxifena func\u021bioneaz\u0103 mai bine cu un substrat osos suficient.<\/li>\n<li>Efectele asupra densit\u0103\u021bii osoase apar la 6\u201312 luni; reducerea riscului de fractur\u0103 este continu\u0103 cu utilizarea \u00eendelungat\u0103.<\/li>\n<li>Reducerea riscului de cancer de s\u00e2n \u00eencepe \u00een c\u00e2teva luni; se men\u021bine pe parcursul anilor de utilizare.<\/li>\n<li>Durat\u0103 tipic\u0103: <strong>5 ani<\/strong> pentru indica\u021biile osoase; <strong>p\u00e2n\u0103 la 5 ani<\/strong> pentru reducerea riscului de cancer de s\u00e2n.<\/li>\n<\/ol>\n<h2><strong>Efecte Secundare<\/strong><\/h2>\n<p><strong>Frecvente:<\/strong> furnic\u0103turi (apari\u021bie nou\u0103 sau agravare \u2014 p\u00e2n\u0103 la 25%), crampe \u00een picioare, edem periferic, simptome asem\u0103n\u0103toare gripei, dureri articulare, transpira\u021bii.<\/p>\n<p><strong>Mai pu\u021bin frecvente:<\/strong> sensibilitate \u00een s\u00e2n, depresie, erup\u021bii cutanate.<\/p>\n<p><strong>Grave (rare):<\/strong> Tromboembolism venos (TEV, EP) \u2014 risc similar cu estrogenul; accident vascular cerebral fatal la femeile postmenopauzale cu boli coronariene (studiu RUTH); tromboz\u0103 venoas\u0103 retinal\u0103.<\/p>\n<h2><strong>Cine nu ar trebui s\u0103 ia Raloxiheal<\/strong><\/h2>\n<ul>\n<li><strong>Tromboembolism venos activ sau \u00een antecedente (TEV, EP)<\/strong> \u2014 raloxifena cre\u0219te riscul de 2\u20133 ori<\/li>\n<li>Femeile cu antecedente de accident vascular cerebral (studiu RUTH a ar\u0103tat o cre\u0219tere a fatalit\u0103\u021bii accidentului vascular cerebral la femeile cu boli coronariene)<\/li>\n<li>Sarcin\u0103 sau femei care ar putea r\u0103m\u00e2ne \u00eens\u0103rcinate<\/li>\n<li>Copii \u0219i adolescen\u021bi<\/li>\n<li>Boal\u0103 hepatic\u0103 activ\u0103<\/li>\n<li>Insuficien\u021b\u0103 renal\u0103 sever\u0103<\/li>\n<li>S\u00e2nger\u0103ri vaginale nediagnosticate (investiga\u021bi \u00eent\u00e2i)<\/li>\n<li>Cancer activ de s\u00e2n sau endometrial (discutat individual)<\/li>\n<\/ul>\n<h2><strong>Raloxifena vs Alternative \u2014 Tabel de decizie<\/strong><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:12px 0;\">\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Obiectiv<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Prima linie<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Rolul Raloxifenei<\/th>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Alinare simptome vasomotori (furnic\u0103turi)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Estrogen \/ tibolon\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Nu este indicat \u2014 agraveaz\u0103 furnic\u0103turile<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">Osteoporoza postmenopauz\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Alendronat \/ al\u021bi bisfosfona\u021bi<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Alternativ\u0103 bun\u0103; cele mai puternice dovezi pentru fractur\u0103 vertebral\u0103<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Reducerea riscului de cancer mamar<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Tamoxifen (la femeile premenopauzale) sau raloxifen (la femeile postmenopauzale)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Profil de efecte adverse mai bun dec\u00e2t tamoxifenul pentru utilizarea postmenopauzal\u0103<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">Obiective combinate pentru os \u0219i cancer de s\u00e2n<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Raloxifene<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Un singur medicament acoper\u0103 ambele<\/td>\n<\/tr>\n<\/table>\n<h2><strong>Depozitare<\/strong><\/h2>\n<p>P\u0103stra\u021bi la temperatura camerei (15\u201325 \u00b0C). P\u0103stra\u021bi \u00een blisterul original, departe de umiditate \u0219i lumin\u0103. P\u0103stra\u021bi departe de copii.<\/p>\n<h2 id=\"faqs\">\u00centreb\u0103ri frecvente<\/h2>\n<h3 class=\"wp-block-heading\">Raloxifenul este acela\u0219i lucru cu estrogenul?<\/h3>\n<p>Nu \u2014 este un modulator selectiv al receptorului de estrogen (SERM). Ac\u021bioneaz\u0103 ca estrogenul \u00een os (efect pozitiv), dar blocheaz\u0103 estrogenul \u00een \u021besutul mamar (tot pozitiv, pentru reducerea riscului de cancer). Efectul asupra uterului este neutru. Spre deosebire de estrogen, NU trateaz\u0103 senza\u021bia de furnic\u0103turi \u2014 le poate \u00eenr\u0103ut\u0103\u021bi.<\/p>\n<h3 class=\"wp-block-heading\">Raloxifenul poate provoca senza\u021bie de furnic\u0103turi?<\/h3>\n<p>Da, la aproximativ 25% dintre utilizatoare \u2014 fie apari\u021bia de noi senza\u021bii, fie agravarea celor existente. Acesta este compromisul clasic al raloxifenului: ob\u021bii protec\u021bie osoas\u0103 \u0219i mamar\u0103, dar nu \u0219i ameliorarea simptomelor.<\/p>\n<h3 class=\"wp-block-heading\">Pot combina raloxifenul cu estrogen?<\/h3>\n<p>Nu \u2014 combina\u021bia anuleaz\u0103 beneficiile. Dac\u0103 ai nevoie de ameliorarea senza\u021biei de furnic\u0103turi \u0219i protec\u021bie osoas\u0103, discut\u0103 op\u021biunile cu un medic: estrogen pe termen scurt mai \u00eent\u00e2i, apoi trecere la raloxifen sau bisfosfonat.<\/p>\n<h3 class=\"wp-block-heading\">C\u00e2t timp trebuie s\u0103 iau Raloxiheal?<\/h3>\n<p>Tratamentele tipice sunt de 3\u20135 ani pentru osteoporoz\u0103; 5 ani pentru prevenirea cancerului de s\u00e2n. Durate mai lungi sunt acceptabile pentru protec\u021bia continu\u0103 \u00eempotriva osteoporozei.<\/p>\n<h3 class=\"wp-block-heading\">Ce zici de calciu \u0219i vitamina D?<\/h3>\n<p>Da \u2014 raloxifena func\u021bioneaz\u0103 cel mai bine \u00een combina\u021bie cu un aport adecvat de calciu (1000\u20131200 mg\/zi) \u0219i vitamina D (800\u20131000 UI\/zi). Acestea furnizeaz\u0103 substratul pe care raloxifena ajut\u0103 s\u0103-l p\u0103streze.<\/p>\n<h3 class=\"wp-block-heading\">Raloxifena reduce riscul de fractur\u0103 de \u0219old?<\/h3>\n<p>Datele din studii (MORE, CORE) arat\u0103 o reducere semnificativ\u0103 a fracturilor vertebrale (~40\u201350%), dar un efect mai pu\u021bin concludent asupra fracturilor de \u0219old. Pentru protec\u021bie axat\u0103 pe fracturile de \u0219old, bisfosfona\u021bii sau denosumabul pot fi prefera\u021bi.<\/p>\n<h3 class=\"wp-block-heading\">Care este riscul de TEV?<\/h3>\n<p>Raloxifena cre\u0219te riscul de TEV de ~2\u20133 ori (similar cu estrogenul). Riscul este cel mai mare \u00een primele 4 luni. \u00centrerupe\u021bi administrarea raloxifenei cu 3 zile \u00eenainte de imobilizare prelungit\u0103, interven\u021bii chirurgicale sau zboruri lungi; relua\u021bi c\u00e2nd sunte\u021bi mobil.<\/p>\n<h3 class=\"wp-block-heading\">Raloxifena este mai sigur\u0103 dec\u00e2t tamoxifenul pentru prevenirea cancerului de s\u00e2n?<\/h3>\n<p>Pentru femeile postmenopauzale, da \u2014 raloxifena are un risc mai mic de cancer endometrial \u0219i mai pu\u021bine evenimente tromboembolice comparativ cu tamoxifenul, cu o reducere similar\u0103 a riscului de cancer de s\u00e2n invaziv (studiu STAR).<\/p>\n<h3 class=\"wp-block-heading\">Produse conexe pentru s\u0103n\u0103tatea hormonal\u0103 \u0219i a femeii<\/h3>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/premarin\/\">Premarin (Estrogeni conjuga\u021bi)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/premarin-cream\/\">Premarin Crem\u0103 (Estrogen vaginal)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/progynova\/\">Progynova (Valerat de estradiol)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/endogest\/\">Endogest (Progesteron\u0103 100 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/gestoford\/\">Gestoford (Progesteron\u0103 100 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/gestheal\/\">Gestheal (Progesteron\u0103 200 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/susten-capsule\/\">Capsule Susten (Progesteron\u0103)<\/a><\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 20px;margin:16px 0;border-radius:4px;font-size:0.9em;\">\n<p style=\"margin:0;\"><strong>\u2695\ufe0f Disclaimer medical:<\/strong> Informa\u021biile au caracter educa\u021bional \u0219i nu \u00eenlocuiesc sfatul medical. Terapiile hormonale prezint\u0103 riscuri specifice (cancer de s\u00e2n, tromboz\u0103 venoas\u0103, accident vascular cerebral, cancer endometrial \u00een cazul estrogenului neopozat) \u2014 consulta\u021bi un medic \u00eenainte de a \u00eencepe, \u00eentrerupe sau modifica orice tratament hormonal. Raportul risc-beneficiu depinde de istoricul medical personal \u0219i familial.<\/p>\n<\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Alternative conexe<\/h3>\n<p>Alte produse din <strong>Afec\u021biuni cronice<\/strong> pe care clien\u021bii le vizualizeaz\u0103 de asemenea:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/foracort-inhaler\/\">Inhalator Foracort<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/hytrin\/\">Hytrin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/dilzem-cd\/\">Dilzem CD<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/calpol\/\">Calpol<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/betnesol-tab\/\">Betnesol Tab<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Sus\u021bine s\u0103n\u0103tatea oaselor<br \/>\n\u2705 Reduce riscul de fracturi<br \/>\n\u2705 Scade nivelul colesterolului<br \/>\n\u2705 Previne osteoporoza<br \/>\n\u2705 Menopause symptom relief<\/p>\n<p>Raloxiheal contains <strong>Raloxifene<\/strong>.<\/p>","protected":false},"featured_media":64855,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[3223,3519,3502],"product_tag":[5324,5323],"class_list":{"0":"post-64854","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-chronic-conditions","7":"product_cat-hormone-replacement-therapy-hrt-medication-for-menopause","8":"product_cat-womens-health","9":"product_tag-raloxifene","10":"product_tag-raloxiheal","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/64854","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=64854"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media\/64855"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=64854"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=64854"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=64854"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=64854"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}